Dianthus Therapeutics Growth Metrics (2017-2025) | DNTH

Growth Metrics Sep2017 Dec2017 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.09M-0.16M-0.02M0.02M0.05M0.03M-0.09M-1.55M-0.81M
EBITDA Margin Growth (3y) -0.86M
EBITDA Margin (QoQ) -0.02M-0.05M0.03M-0.05M-0.09M0.09M0.06M-0.02M-0.11M-0.03M-1.40M0.72M
EBIT Margin Growth (1y) -0.10M-0.21M-0.05M-0.00M0.03M0.06M-0.08M-1.69M-0.88M
EBIT Margin Growth (3y) -0.95M
EBIT Margin (QoQ) -0.02M-0.06M0.04M-0.05M-0.13M0.10M0.08M-0.02M-0.10M-0.04M-1.52M0.79M
EBT Margin Growth (1y) -0.09M-0.16M-0.01M0.02M0.04M0.04M-0.10M-1.54M-0.81M
EBT Margin Growth (3y) -0.86M
EBT Margin (QoQ) -0.02M-0.06M0.03M-0.05M-0.09M0.09M0.06M-0.02M-0.09M-0.04M-1.38M0.71M
Enterprise Value Growth (1y) 555.32%493.37%189.97%11.61%0.57%859.94%-72.50%-62.97%-29.85%-133.81%86.54%-497.54%61.97%10,799.76%4,403.53%478.59%1,986.34%-36.52%-14.32%65.33%
Enterprise Value Growth (3y) 57.16%68.40%-67.98%-30.30%-28.01%-28.38%-26.83%-27.59%-41.44%184.24%90.95%240.28%
Enterprise Value Growth (5y) -1.55%17.36%0.00%-15.23%-20.92%-19.36%3.50%4.24%17.12%-3.64%22.34%23.28%39.02%
Enterprise Value (QoQ) 6.00%13.98%-18.79%-80.33%813.67%-23.54%-26.82%87.77%-73.83%2.96%38.62%-594.96%66.45%-123.24%90.88%-97.01%-1,389.40%85.79%2,666.46%-20.76%31.02%-29.21%-13.64%6.96%152.81%
FCF Margin Growth (1y) -0.25M-0.20M0.03M-0.03M0.01M0.07M-0.07M-1.16M-0.67M
FCF Margin Growth (3y) -0.91M
FCF Margin (QoQ) -0.22M-0.13M0.16M-0.06M-0.17M0.11M0.09M-0.02M-0.11M-0.03M-1.00M0.47M
Net Margin Growth (1y) -0.09M-0.16M-0.01M0.02M0.04M0.04M-0.10M-1.54M-0.81M
Net Margin Growth (3y) -0.86M
Net Margin (QoQ) -0.02M-0.06M0.03M-0.05M-0.09M0.09M0.06M-0.02M-0.09M-0.04M-1.38M0.71M
Operating Margin Growth (1y) -0.10M-0.21M-0.05M-0.00M0.03M0.06M-0.08M-1.69M-0.88M
Operating Margin Growth (3y) -0.95M
Operating Margin (QoQ) -0.02M-0.06M0.04M-0.05M-0.13M0.10M0.08M-0.02M-0.10M-0.04M-1.52M0.79M
Return on Assets Growth (1y) -10.00-10.00-13.00-12.00-6.006.0021.0033.0029.0013.000.00M-10.00-19.00-9.00
Return on Assets Growth (3y) 0.00M1.002.005.0012.0010.00
Return on Assets Growth (5y) -4.0011.0022.0023.0019.0022.0026.0016.0016.00
Return on Assets (QoQ) -7.00-5.002.000.00M-8.00-8.004.006.00-6.00-7.007.0013.008.006.003.00-4.00-5.00-5.00-6.006.00
Return on Capital Employed Growth (1y) -13.00-15.00-18.00-13.00-6.006.0022.0037.0031.0014.00-2.00-13.00-22.00-9.00
Return on Capital Employed Growth (3y) 0.00M4.004.006.0011.0011.00
Return on Capital Employed Growth (5y) -7.0011.0024.0025.0019.0024.0029.0015.0016.00
Return on Capital Employed (QoQ) -8.00-6.001.000.00M-10.00-9.006.008.00-6.00-9.008.0012.0010.006.003.00-5.00-5.00-5.00-7.008.00
Return on Equity Growth (1y) -12.00-13.00-18.00-14.00-7.0055.00-163.00-108.00-80.0054.001.00-11.00-21.00-10.00
Return on Equity Growth (3y) -87.00189.00151.00120.00-25.0098.00
Return on Equity Growth (5y) -44.0013.0025.0026.0022.0026.0032.0019.0019.00
Return on Equity (QoQ) -8.00-6.002.000.00M-10.00-11.006.008.00266.00-49.00-25.00-138.0048.007.003.00-4.00-5.00-5.00-7.007.00
Return on Sales Growth (1y) -442.00-64.00168.0013.00-976.00-0.00M
Return on Sales (QoQ) -256.00-330.00-26.00170.00122.00-98.00-182.00-818.00-0.00M